This blog post belongs to a series, presumptuously titled NYUlab, about interesting thoughts and experiences I have as I pursue an MA in science, health and environmental reporting at New York University.
“The paper has been through many financial crises and Science Times has not been affected.” These were the words of David Corcoran, Editor, NYT Science Times, who’d dropped by my NYU SHERP class today for a short presentation and some Q&A. David said that in response to the question “How easy or difficult is it to make money off the science section on nytimes.com and the newspaper?” that I’d asked him. His reply in full went like this:
Not something the Times has been worried out. Going back to 1978 [when Science Times was launched], the paper was facing a lot of pressure. The top management came up with publishing special sections every day and the hope was to attract more advertising. [Once the other days were decided,] There was a question about what to do about Tuesday. There was a lively debate between the news and business sides. The business side wanted fashion but the top news editors said that’s not The New York Times and they came up with the idea of a science section. They knew it wouldn’t be a big money maker – it never has been. We have a big ad on the last page today but that’s unusual.
The future of newspapers is very much in doubt and the reason is that the old business model which was selling those newspaper ads is rapidly going away. They’re still a significant source of revenue but much, much smaller than they were even 10 years ago, even five years ago. So the question is how we’re going to replace that source of revenue. The ads in videos don’t bring in nearly as much money, and I don’t know why. Science Times is very central to the identity of the newspaper, and it’s not going to go away. The paper has been through many financial crises and Science Times has not been affected.
In response to someone else’s question, he said: Wrapping your mind around a subject like stem cells is not what [editors of other desks] have a lot of time for, so we get to do our own thing most of the time.
Sounds like the science section of The New York Times in print (much like at The Hindu) exists in order to fulfill some kind of institutional ambition more than being a logical conclusion backed by the commensurate resources. If only to me, this sounds like a precarious position to be in for many reasons. Foremost, depending on ideological over business interests means the science section is susceptible to ideological over business forces. And ideological forces are often much less rational, unpredictable and, most importantly, accountable.
Could it be that science editors are reluctant to acknowledge that their department in a publication is situated in a bubble that protects them from financial pressures? There’s no doubt that The New York Times does some excellent science reporting and analysis, and wins many awards doing it, but there’s a part of me wondering how much – and in what ways – this would change if science editors were pulled up and asked to start showing profits from their work. It’d be a brutal thing to do, no doubt, asking such gentle creatures to figure out a business model that even political editors are confused about. But it would also level the playing field, give the science department some bargaining power, and let journalists explore if there’s any way to eliminate the subsidization of science news.
Cutting back: my classmates as such had a lot of questions for David Corcoran. I’d like to reproduce his answers to two that pertained to specific stories that appeared today (September 16).
How do you decide if it’s time to reintroduce an issue in the news, like with Karen Weintraub’s piece today [on stem cells research]?
It’s an important subject and it’s overdue for an update. There’d been a lot of hype but not been many major breakthroughs yet. We brainstormed with the writer and photo editor and art director and figured out the best way to show this. We went to researchers and got a striking picture. The picture inside would’ve given a false impression because not everybody comes from stem cells treatment and the next day, be break-dancing.
Dennis [Overbye] went to England and ended up having lunch with Peter Higgs. I let him write it, he was a little starstruck. And he turned it in without any fanfare, he just sent it to me. I did a wordcount, it was 1,600 words, 600 words more than [we could fit]. But then I read it and said, “Wow, that’s fabulous”. Dennis’s strongpoint is explaining these difficult ideas. So we held another piece and included Dennis’s piece in the cover. [When asked about the staid choice of picture] With that particular columnist, there’s an artist, and they like each other’s work, so we let them go with it.
Overall, David comes across as an unassuming, deliberative and very helpful person in his role as the editor of Science Times. I say helpful because, when asked how much time he spends mentoring freelancers, he said, “I spend quite a bit more time working with [promising freelancers] because there are lots of people like you who are just starting out and how are they going to start out if nobody takes them seriously? I would hope there are lots of other editors doing a similar thing.” Thanks very much for dropping by, David, and it’s good to know a newspaper as daunting as The New York Times has someone like you who makes people like me feel less intimidated.